Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Change in Accured Expenses: 2019-2024

Historic Change in Accured Expenses for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Dec 2024 value amounting to -$22.8 million.

  • Maravai Lifesciences Holdings' Change in Accured Expenses rose 243.24% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.3 million, marking a year-over-year increase of 151.84%. This contributed to the annual value of -$22.8 million for FY2024, which is 250.61% down from last year.
  • Latest data reveals that Maravai Lifesciences Holdings reported Change in Accured Expenses of -$22.8 million as of FY2024, which was down 250.61% from $15.1 million recorded in FY2023.
  • In the past 5 years, Maravai Lifesciences Holdings' Change in Accured Expenses registered a high of $17.8 million during FY2020, and its lowest value of -$22.8 million during FY2024.
  • Moreover, its 3-year median value for Change in Accured Expenses was $8.5 million (2022), whereas its average is $285,667.
  • In the last 5 years, Maravai Lifesciences Holdings' Change in Accured Expenses soared by 407.19% in 2020 and then slumped by 250.61% in 2024.
  • Over the past 5 years, Maravai Lifesciences Holdings' Change in Accured Expenses (Yearly) stood at $17.8 million in 2020, then crashed by 119.45% to -$3.5 million in 2021, then skyrocketed by 345.96% to $8.5 million in 2022, then soared by 77.68% to $15.1 million in 2023, then tumbled by 250.61% to -$22.8 million in 2024.